206650.KS · 유바이오로직스
South Korea · RS rating 21 · As of 2026-10-14
| Price | 8,070.00 KRW |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 21 / 32 / 46 / 21 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 29 / 8 / 35 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +104.0% |
| Sales growth Q/Q | +112.4% |
| Distance from 52-week high | +50.2% |
| Market cap (USD) | $227.2M |